Gene chromosomal organization and expression in cultured human neurons exposed to cocaine and HIV-1 proteins gp120 and tat: Drug abuse and NeuroAIDS

Frontiers in Bioscience

Volumn 11, Issue 2 P.1591-2006, 2006, Pages 1774-1793

  Shapshak, Paul ^a   Duncan, Robert ^a   Nath, Avindra ^b   Turchan, Jadwiga ^c   Kangueane, Pandjassarame ^d   Rodriguez, Hector ^a   Duran, E Margarita ^a   Ziegler, Fabians ^a   Amaro, Eric ^a   Lewis, Apple ^a   Rodriguez, Alejandro ^a   Minagar, Alireza ^e,f   Davis, Wade ^g   Seth, Raman ^h,i   Elkomy, Fatten F ⁱ   Chiappelli, Francesco ^j   Kazic, Toni ^h,i  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF KENTUCKY   (United States)

^d NANYANG TECHNOLOGICAL UNIVERSITY   (Singapore)

^e Louisiana State University School of Medicine Shreveport   (United States)

^f LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^g BAYLOR UNIVERSITY   (United States)

^h University of Missouri   (United States)

ⁱ University of Missouri   (United States)

^j UCLA SCHOOL OF DENTISTRY   (United States)

more..

Author keywords

Affymetrix; AIDS; Ariadne Pathways Assist; Bioinformatics; Chromosome Damage; Cocaine; Coerced Transcription; Culture; Encephalitis; Gene Expression; gp120; HIV Associated Dementia (HAD); HIV 1; Human; Microarray; Neuron; Tat; Transcription Isolation

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 32844463565     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/1922     Document Type: Article

References (95)

1. Nath, A., Hauser, K. F., Wojna, V., Booze, R. M., Maragos, W., Prendergast, M., Cass, W., and Turchan, J. T.: Molecular Basis for Interactions of HIV and Drugs of Abuse. J AIDS 31 Supplement 2: S62-S69, (2002)
2. Bureau of Justice Statistics. Drug and Crime Facts. http://www.ojp.usdoj. gov/bjs/ (2005)
3. National Institute on Drug Abuse. Cocaine Abuse and Addiction. Research Report Series, (1998)
4. Resnick, L., Berger, J. R., Shapshak, P., and Tourtellotte, W. W.: Early penetration of the blood- brain barrier by HTLV-III/LAV. Neurology 8, 9-15 (1988)
5. Singer, E. J., Syndulko, K., Fahy-Chandon, B. N., Shapshak, P., Resnick, L., Schmid, P., Conrad, A. J., and Tourtellotte W. W.: Cerebrospinal fluid p24 antigen levels and intrathecal immunoglobulin G synthesis are associated with cognitive disease severity in HIV-1. AIDS 8, 197-204 (1994)
6. Dal Pan, G. J., McArthur, J. H., Aylward, E., Selnes, O. A., Nance-Sproson, T. E., Kumar, A. J., Mellits, E. D., McArthur, J. C.: Patterns of cerebral atrophy in HIV-1-infected individuals: results of a quantitative MRI analysis. Neurology 42, 2125-2131 (1992)
7. Pang S, Koyanagi Y, Miles S, Wiley C, Vinters HV, and Chen I. S. Y.: High levels of unintegrated HIV-1 DNA in brain tissue of AIDS dementia patients. Nature 85-89, (1990)
8. Gorry, P. R., Bristol, G., Zack, J. A., Ritola, K., Swanstrom, R., Birch, C. J., Bell, J. E., Bannert, N., Crawford, K., Wang, H., Schols, D., De Clercq, E., Kunstman, K., Wolinsky, S. M., Gabuzda, D.: Macrophage tropism of HIV-1 isolates from brain and lymphoid tissues predicts neurotropism independent of Coreceptor specificity. J Virol 75, 10073-10089 (2001)
9. Chang, J., Jozwiak, R., Wang, B., Ng, T., Ge, Y. C., Bolton, W., Dwyer, D. E., Randle, C., Osborn, R., Cunningham, A. L., Saksena, N.K.: Unique HIV type 1 V3 region sequences derived from six different regions of brain: region-specific evolution within host-determined quasispecies. AIDS Res Hum Retroviruses 14, 25-30 (1998)
10. Shapshak, P., Segal, D. M., Crandall, K., Fujimura, R. K., Zhang, B. T., Xin, K. O., Okuda, K., Petito, C., Eisdorfer, C., Goodkin, K.: Independent evolution of HIV-1 in different brain regions. AIDS Res & Hu Retro 15, 811-801 (1999)
11. Gartner, S.: HIV Infection and Dementia. Science, 287, 602-604, (2000)
12. Gartner, S. and Liu, Y.: Insights into the role of immune activation in HIV neuropathogenesis. J Neurovirol 8, 69-75, (2002)
13. Nuovo, G. J., Gallery, F., MacConnell, P., and Braun, A.: In Situ Detection of Polymerase Chain Reaction-Amplified HIV-1 Nucleic Acids and Tumor Necrosis Factor-a RNA in the Central Nervous System. Am J Path 144, 659-665 (1994)
14. Tornatore, C., Chandra, R., Berger, J. R. and Major, E. O.: HIV-1 infection of subcortical astrocytes in the pediatric central nervous system. Neurol 44, 481-487 (1994)
15. Bagasra, O., Lavi, E., Bobroski, L., Khalili, K., Pestaner, J. P., Tawadros, R., and Pomerantz, R. J.: Cellular reservoirs of HIV-1 in the central nervous system of infected individuals: identification by the combination of in situ polymerase chain reaction and immunohistochemistry. AIDS 10, 573-585 (1996)
16. Gendelman HE, Lipton SA, Tardieu M, Bukrinsky MI, and Nottet ASLM, The Neuropathogenesis of HIV-1 infection. J Leuko Biol 56, 389-398 (1994)
17. Shapshak, P., Yoshioka, M., Sun, N. C. J., and Schiller, P.: The use of combined in situ hybridization and immunocytochemistry to identify HIV-1 infected cells in brain tissue. Modern Pathology 5, 649-654 (1992)
18. Achim, C. L., Wang, R., Miners, D. K., and Wiley, C. A. Brain Viral Burden in HIV Infection. J. Neuropathol. Exp. Neurol; 53: 284-294, (1994)
19. Bell, J. E., Brettle, R. P., Chiswick, A., and Simmonds, P.: HIV encephalitis, proviral load, and dementia in drug users and homosexuals with AIDS. Effects of neocortical involvement. Brain 121, 2043-2052 (1998)
20. Masliah, E., Ge, N., Achim, C. L., DeTeresa, R., and Wiley, C. A.: Patterns of Neurodegeneration in HIV Encephalitis. J Neuro-AIDS 1, 161-173 (1996)
21. Gendelman, H. E.: Neural immunity: Friend or foe? J Neurovirol 8, 474-479 (2002)
22. Shapshak, P., Duncan, D., Minagar, D., Rodriguez de la Vega, P., Stewart, R., Petito, C. K.: Elevated expression of IFN-γ in the HIV-1 infected brain. Front Biosci 9, 1073-1081 (2004)
23. Adamson, D. C., Kopnisky, K. L., Dawson, T. M., Dawson, V. L.: Mechanisms and structural determinants of HIV-1 coat protein, gp41-induced neurotoxicity. J Neurosci 19, 64-71 (1999)
24. Lipton, S. A. and Gendelman, H. E.: Dementia Associated with the Acquired Immunodeficiency Syndrome. N Eng J Med 332, 934-940 (1995)
25. Heyes, M. P., Saito, K., Major, E. O., Milstien, S., Markey, S. P., and Vickers J. H.: A mechanism of Quinolinic acid formation by brain in inflammatory neurological disease. Attenuation of synthesis from L-tryptophan by 6-chlorotryptophan and 4-chloro-3-hydroxyanthranilate. Brain 116(Pt 6), 1425-1450 (1993)
26. Kuljis, R. O., Shapshak, P., Rodriguez de la Vega, P., and Petito, C.: Increased density of Neurons containing NADPH diaphorase/nitric oxide synthase in the cerebral cortex of patients with HIV-1 infection & drug abuse. J NeuroAIDS 2, 19-36 (2003)
27. Shapshak, P., Fujimura, R. K., Srivastava, A., Goodkin, K.: Dementia and the Neurovirulence of HIV-1, CNS Spectrums. An International Psychiatry Journal 5, 31-42 (2000)
28. Wesselingh, S. L., Power, C., Glass, J. D., Tyor, W. R., McArthur, J. C., Farber, J. M., Griffin, J. W., and Griffin, D. E.: Intracerebral Cytokine Messenger RNA Expression in Acquired Immunodeficiency Syndrome Dementia. Ann Neurol 33, 576-582 (1993)
29. Gonzales-Scarano, F.: Chemokines and apoptosis in HIV Dementia. J Neurovirol 6, 242-244, (2000)
30. Persidsky, Y., Limoges, J., Ghorpade, A., Nukuna, A., Heimman, D. and Poluektova, L.: Utility of SCID mouse model for HIV-1 viral genetic studies in the CNS, in Viral and host genetic factors regulating HIV CNS Disease, Washington Marriott, Washington, DC, (2002)
31. MacLean, A. G., Orandle MS, MacKey J, Williams, K. C., Alvarez, X., and Lackner A. A.: Characterization of an in vitro rhesus macaque blood-brain barrier. J Neuroimmunol 131(1-2), 98-103 (2002)
32. Strelow, L. I., Watry, D. D., Fox, H. S., and Nelson, J. A.: Efficient infection of brain microvascular endothelial cells by an in vivo-selected neuroinvasive SIVmac variant. J Neurovirol, 4, 269-80 (1998)
33. Hodge, S., de Rosayro, J., Glenn, A., Ojukwu I. C., Dewhurst, S., McClure, H. M., Bischofberger, N., Anderson, D., Klumpp, S. A., and Novembre, F. J.: Postinoculation PMPA treatment, but not preinoculation immunomodulatory therapy. Protects against Development of Acute Disease Induced by the Unique Simian Immunodeficiency Virus SIVsmmPBj. J Virol 73, 8630-8639 (1999)
34. Clements, J. E., Weed, M., Carruth, L. M., Li, M., Gama, L., Queen, S., Mankowski, J. L., and Zink, M.: Morphine and cocaine treatment affect the development of SIV CNS disease: a model of HIV dementia, p. 30, The 10th Annual Meeting on Neuroimmune Circuits and Infectious Diseases, [Society on Neuroimmune Pharmacology (SNIP)], Santa Fe, NM (2004)
35. Subbiah, P., Mouton, P., Fedor, H., McArthur, J. C., and Glass, J. D.: Stereological Analysis of Cerebral Atrophy in Human Immunodeficiency Virus-associated Dementia. J Neuropath ExpNeurol 55, 1032-1037 (1996)
36. Petito, C. K., Torres-Munoz, J., and Bookman, R. J.: Regional compartmentalization of HIV in the CNS, Viral and Host Genetic Factors Regulating HIV/CNS Disease Washington Marriott, Washington, DC, Proceedings, pp 9 (2002)
37. Wiley, C. A. and Achim, C.: Human Immunodeficiency Virus Encephalitis is the Pathological Correlate of Dementia in Acquired Immunodeficiency Syndrome. Ann Neurol 36, 673-676 (1994)
38. Dixon, S. D. and Bejar, R.: Echoencephalographic findings in neonates associated with maternal cocaine and methamphetamine use: incidence and clinical correlates. J Pediatr 115(5 Pt 1), 770-778 (1989)
39. Delgado, S., Shapshak, P., Stewart, R. V., Rodriguez de la Vega, P., Benjamin, S., and Bradley, W.: Heterogeneity of macrophages in the peripheral nervous system in HIV-1 infected individuals. J NeuroAIDS 2, 79-97 (1998)
40. Shapshak, P., Stewart, R. V., Rodriguez de la Vega, P., Dominguez, B., Fujimura, R., Segal, D. M., Petito, C.: Brain macrophage surface marker expression with HIV-1 infection & drug abuse; apreliminary study. J NeuroAIDS 2, 37-50 (2002)
41. Shapshak, P., Crandall, K. A., Xin, K. Q., Goodkin, K., Fujimura, R, K.: HIV-1 Neuropathogenesis and Abused Drugs, Current Views, Problems, and Solutions. AIDS, Drugs of Abuse, and the Neuroimmune Axis. Plenum Press, New York pp.171-186 (1996)
42. Wigdahl, B. and Hogan, T.: Molecular determinants of HIV-1 CNS disease progression, viral and host genetic factors regulating HIV/CNS disease. Washington Marriott, Washington, DC, Proceedings, pp 5, (2002)
43. Nagano, I., Shapshak, P., Yoshioka, M., Xin, K. Q., Nakamura, S., and Bradley, W. G.: Increased NADPH-diaphorase reactivity and cytokine expression in dorsal root ganglia in AIDS. J Neuro Sci 136, 117-128 (1996)
44. Tyor, W. R., Glass, J. D., Griffin, J. W., Becker, P. S., McArthur, J. C., Bezman L, et al. Cytokine expression in the brain during the acquired immunodeficiency syndrome. Ann Neurol 31, 349-360 (1992)
45. Tyor, W. R., and Middaugh, L. D.: Do alcohol and cocaine abuse alter the course of HIV-associated dementia complex? J Leukoc Biol 65, 475-479 (1999)
46. Goodkin, K., Shapshak, P., Metsch, L. R., McCoy, C. B., Crandall, K. A., Kumar, M.: Cocaine abuse and HIV-1 infection: Epidemiology and neuropathogenesis. J Neuroimmunol 83, 88-101 (1997)
47. Bailey, D. N.: Cocaine detection during toxicology screening of a university medical center patient population. J Toxicol Clin Toxicol 25(1-2), 71-79 (1987)
48. Chaudhry, I. A., Turkanis, S. A. and Karler, R.: Characterization of "reverse tolerance" to amphetamine-induced locomotor stimulation in mice. Neuropharmacol 27, 777-781 (1988)
49. Itzhak, Y.: Modulation of Cocaine- and Methamphetamine-Induced Behavioral Sensitization by Inhibition of Brain Nitric Oxide Synthase. J Pharmacol Exp Therap 282, 521-527 (1997)
50. Langford, D., Grigorian, A., Hurford, R., Crews A. A., and Masliah, E.: The role of mitochondrial alterations in the combined toxic effects of HIV tat protein and methamphetamine on Calbindin-positive neurons. J Neurovirol 10, 327-337 (2004)
51. th Annual Scientific meeting of the CPDD, NIDA Monograph Series Volume 185, 82-99 (2005)
52. Dreyer EB et al, HIV-1 coat protein neurotoxicity prevented by Calcium channel antagonists, Science 248, 364-367 (1990)
53. Lipton, L.: Memantine prevents HIV coat protein-induced neuronal injury in vitro. Neurology 42, 1403-1405 (1992)
54. Nath, A., Haughey, N. J., Jones, M., Anderson, C., Bell, J. E., and Geiger, J. D.: Synergistic neurotoxicity by HIV proteins tat and gp120: protection by memantine. Ann Neurol 7, 186-194 (2000)
55. Diop, A. G., Lesort, M., Esclaire, F., Dumas, M., and Hugon, J.: Calbindin D28K-containing neurons, and not HSP70-expressing neurons, are more resistant to HIV-1 envelope (gp120) toxicity in cortical cell Cultures. J Neurosci Res 42, 252-258 (1995)
56. Howard, S. A.: Glucocorticoid modulation of gp120-induced effects on calcium-dependent degenerative events in primary hippocampal and cortical cultures. Exp Neurol 158, 164-170 (1999)
57. Savio, T., and Levi, G.: J Neurosci Res 34, 265-272 (1993)
58. Navarra, M.: Ethanol exposure inhibits the cytotoxic effect induced by gp120 in CHP100 human neuroblastoma cells. J Neurosci Res 65, 354-361 (2001)
59. Koller, H., Schaal, H., Freund, M., Garrido, S. R., von Giesen, H. J., Ott, M., Rosenbaum, C., Arendt, G.: Eur J Neurosci 14, 1793-1799 (2001)
60. Gu J, Yassini, P., Goldberg, G., Zhu, W., Konat, G. W., Wiggins, R. C.: Cocaine cytotoxicity in serum-free environment: C6 glioma cell culture. Neurotoxicol 14, 19-22 (1993)
61. Kapasi, A. A., Fan, S., Singhal, P. C.: Role of 14-3-3ε, c-Myc/Max, and Akt phosphorylation in HIV-1 gp120-induced mesangial cell proliferation. Am J Physiol Renal Physiol 280, 333-342 (2001)
62. Miyagi, T., Chuang, L.F., Doi, R.H., Carlos, M.P., Torres, J.V. and Chuang, R.Y.: Morphine Induces Gene Expression of CCR5 in Human CEMx174 Lymphocytes. J Biol Chem 275, 31305-31310 (2000)
63. Gekker, G., Hu, S., Wentland, M. P., Bidlack, J. M., Lockensgard, J. R., Peterson, P. K.: {kappa}-Opioid receptor ligands inhibit cocaine-induced HIV-1 expression in microglial cells. J Pharmacol Exp Ther 309, 6000-6006 (2004)
64. Klein, T. W., Newton, C., Larsen, K., Nong, L., Lu, L. T., Perkins, I., and Friedman, H.: Cannabinoid modulation of T helper cells, page 27, The 10th Annual Meeting on Neuroimmune Circuits and Infectious Diseases, [Society on Neuroimmune Pharmacology (SNIP)], Santa Fe, NM (2004)
65. Magnuson, D. S., Knudsen, B. E., Geiger, J. D., Brownstone, R. M., and Nath, A.: Ann Neurol 37, 373-380 (1995)
66. Nath, A., Psooy, K., Martin, C., Knudsen, B., Magnuson, D. S., Haughey, N., Geiger, J. D.: Identification of a human immunodeficiency virus type 1 Tat epitope that is neuroexcitatory and neurotoxic. J Virol 70, 1475-1480 (1996)
67. Ma, M., and Nath, A.: Molecular determinants for cellular uptake of Tat protein of human immunodeficiency virus type 1 in brain cells. J Virol 71, 2495-2499 (1997)
68. Turchan, J., Anderson, C., Hauser, K. F., Sun, Q., Zhang, J., Liu, Y., Wise, P. M., Kruman, I., Maragos, W., Mattson, M. P., Booze, R., and Nath, A.: Estrogen protects against the synergistic toxicity by HIV proteins, methamphetamine and cocaine. BMC Neurosci 2(1), 3 (2001)
69. Liu, G., Loraine, A. E., Shigeta, R., Cline, M., Cheng, J., Valmeekam, V., Sun, S., Kulp, D., and Siani-Rose, M. A.: NetAffx: Affymetrix probesets and annotations. Nucleic Acids Res 31, 82-86 (2003)
70. Shapshak, P., Duncan, R., Nath, A., Turchen, J., Davis, W., Duran, E. M., Ziegler, F., Minagar, A., Seth, R., and Kazic, T.: Gene Expression in Human brain and Cultured Human Neurons Exposed to cocaine and HIV-1 proteins gp120 and tat, 8th World Multiconference on Systemics, Cybernetics and Informatics (SCI 2004), Orlando, FL, (2004)
71. Masliah, E., Robert, E. S., Langford, D., Everall, I., Crews, L., Adam, A., Rockenstein, E., Fox, H. S.: Patterns of gene dysregulation in the frontal cortex of patients with HIV encephalitis. J Neuroimmunol 157, 163-175 (2004)
72. Minagar, A., Shapshak, P., Duran, E. M., Kablinger, A. S., Alexander, J. S., Kelley, R. E., Seth, R., and Kazic, T.: Gene expression in HIV-Associated Dementia, Alzheimer's disease, Multiple Sclerosis, and Schizophrenia. J Neurol Sci 224, 3-17 (2004)
73. Shapshak, P., Minagar, A., Duran E. M., Ziegler, F., Davis, W., Seth, R., and Kazic, T.: Gene Expression in HIV Associated Dementia, In: Inflammatory Disorders Of The Nervous System, Clinical Aspects, Pathogenesis, and Management Edited by: Alireza Minagar, MD and J. Steven Alexander, PhD, Published by: Humana Press, Totowa, NJ, pp. 305-318 (2005)
74. Shapshak, P. and Stengel, R.: Discovering Brain Mechanisms and the rules of Molecular Biology, 6th World Multiconference on Systemics, Cybernetics and Informatics, www.iiis.org/sci2002/ Orlando, FL, (2002)
75. Shapshak, P., Duncan, R., Torres-Munoz, J. E., Duran, E. M., Minagar, A., and Petito, C. K.: Analytic approaches to differential Gene Expression in AIDS vs. Control Brains. Front Biosci 9, 2134-2146 (2004)
76. Duncan, R., Shapshak, P., Shaw, S., Nath, A., Turchen, J., Davis, W., Duran, E. M., Ziegler, F., Minagar, A., Seth, R., and Kazic, T.: Repeated-Measures Analysis of Variance of Gene Expression Data in Human brain and Cultured Human Neurons Exposed to cocaine and HIV-1 proteins gp120 and tat, 8th World Multiconference on Systematics, cybernetics, and informatics, Orlando, Florida (2004)
77. Winer, B. J., Brown, D. R., and Michels, K. M. Statistical Principles in Experimental Design, 3rd Ed. McGraw-Hill, Boston, pp. 497-582 (1991)
78. Emptage, M. R., Hudson-curtis, B., and Sen, K.: Treatment of microarray experiments as split-plot designs. J Biopharm Stat 13, 159-178 (2003)
79. Lindahl, B., Westling, C., Giménez-Gallego, G., Lindahl, U., and Salmivirta, M.: Common binding sites for □-Amyloid fibrils and fibroblast growth factor-2 in heparan sulfate from human cerebral cortex. J Biol Chem 274, 30631-30635 (1999)
80. Shapshak, P., Xin, K. Q., Srivastava, A. K., Nagano, I., Stewart, R., Bradley, W., McCoy, C. B., Pardo, V., Goodkin, K., Lai, S., Wood, C., Shah, S. M., Schiller, P., Davis, T., Perez, M., Cuelez, G., Yoshioka M, Nakamura, S., Fiala, M., Sun, N., Chiappelli, F., and Rhode, R.: AIDS neuropathogenesis: cytokines and viral strain, in Pathogenesis of HIV Infection of the Brain: Impact on Function and Behavior Chantilly, Virginia (1994)
81. Shapshak, P., Yoshioka, M., Srivastava, A., Stewart, R., Xin, K. Q., Nelson, S., Wood, McCoy, C., Mash, D. C., Bradley, W., Berger, J., Shah, S., Davis, T., Perez, M., Valloric, D., and Nakamura, S.: Pathogenesis of AIDS encephalitis in drug abusers. NIDA Research Monograph Series 141, 61 (1994)
82. Kuhar, M. J., Joyce, A., Dominguez, G.: Genes in drug abuse-Commentary. Drug and Alcohol Dependence 62, 157-162 (2001)
83. Kang, D. E., Soriano, S., Frosch, M. P., Collins, T., Naruse, S., Sisodia, S. S., Leibowitz, G., Levine, F., and Koo, E. H.: Presenilin-1 facilitates the constitutive turnover of beta-catenin: differential activity of Alzheimer's disease-linked PS1 mutants in the beta-catenin signaling pathway. J Neurosci 19(11):4229-4237 (1999)
84. Barth, A. I., Nathke, I. S., and Nelson, W. J. Cadherins.: Catenins and APC protein: interplay between cytoskeletal complexes and signaling pathways. Curr Opin Cell Biol 9, 683-90 (1997)
85. Dale, T. C. Signal transduction by the WNT family of ligands. Biochem J 329 (Pt 2), 209-223 (1998)
86. Irving, N. G., and Miller, C. C. J.: Tau phosphorylation in cells transfected with wild-type or an Alzheimer's disease mutant Presenilin-1. Neurosci Lett 222, 71-74 (1997)
87. Levesque, G., Yu, G., Nishimura, M., Zhang, D. M., Levesque, L., Yu, H., Xu, D., Liang, Y., Rogaeva, E., Ikeda, M., Duthie, M., Murgolo, N., Wang, L., VanderVere, P., Bayne, M. L., Strader, C. D., Rommens, J. M., Fraser, P. E., and St George-Hyslop, P.: Presenilins interact with armadillo proteins including neural-specific plakophilin-related protein and beta-catenin. J Neurochem 72, 999-1008 (1999)
88. Murayama, M., Tanaka, S., Palacino, J., Murayama, O., Honda, T., Sun, X., Yasutake, K., Nihonmatsu, N., Wolozin, B., and Takashima, A.: Direct association of presenilin-1 with beta-catenin. FEBS Lett 433, 73-77 (1998)
89. Nishimura, M., Yu, G., Levesque, G., Zhang, D. M., Ruel, L., Chen, F., Milman, P., Holmes, E., Liang, Y., Kawarai, T., Jo, E., Supala, A., Rogaeva, E., Xu, D. M., Janus, C., Levesque, L., Bi, Q., Duthie, M., Rozmahel, R., Mattila, K., Lannfelt, L., Westaway, D., Mount, H. T., Woodgett, J., Fraser, P. E., and St George-Hyslop, P.: Presenilin mutations associated with Alzheimer disease cause defective intracellular trafficking of beta-catenin, a component of the presenilin protein complex. Nat Med 164-169 (1999)
90. Schurov, I. L., Handford, E. J., Brandon, N. J. and Whiting P. J.: Expression of disrupted in schizophrenia 1 (DISC1) protein in the adult and developing mouse brain indicates its role in neurodevelopment Molec Psychiat 9, 1100-1110 (2004)
91. Garcia, E., Pion, M., Pelchen-Matthews, A., Collinson, L., Arrighi, J. F., Blot, G., Leuba, F., Escola, J. M., Demaurex, N.Marsh, M., Piguet, V.: HIV-1 Trafficking to the Dendritic Cell-T-Cell Infectious Synapse Uses a Pathway of Tetraspani Sortinto the Immunological Synapse. Traffic 6, 488-501 (2005)
92. Levy, S., and Tsipi, S.: The Tetraspanin Web Modulates Immune-signaling complexes. Nature 5, 136-148 (2005)
93. Fourel, G., Boscheron, C., Revardel, E., Lebrun, E., Hu, Y-F., Simmen, K. C., Muller, K., Li, R., and Gilson, E.: An activation-independent role of transcription factors in insulator function. EMBO Reports 2, 124-132 (2001)
94. Du, M., Beatty L. G., Wenjing, Z., Lew, J., Schoenherr, C., Weksberg, R., and Sadowski, P. D.: Insulator and silencer sequences in the imprinted region of human chromosome 11p15.5, Human. Molecular Genetics, 12, 1927-1939 (2003)
95. Li, H., Jian, Y., Rajpurkar, R., Dunbar, J., and Dhabuwala, C. B.: Cocaine induced apoptosis in rat testes. J Urol 162, 213-216 (1999)